SRPT
Sarepta TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
SRPT vs peer average
76/100
SRPT vs. peer average (B vs. D)
Grade spread
B 3 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biopharma comparator with materially greater scale; useful for sector context but not a direct rare-disease or gene-therapy operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SRPT
Sarepta Therapeutics
AMGN
Amgen
Grade
B
D
Momentum
85
70
Value
51
63
Sentiment
65
43
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
SRPT / AMGN
Grade Position
Above peers
SRPT vs. peer average (B vs. D)
76/100
Momentum
85
SRPTValue
51
AMGNSentiment
65
SRPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SRPT
AMGN is the first peer returned for this comparison set.